Related Experiment Video
Updated: Aug 15, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
[Cardiac infection]
1Department of Internal Medicine, Tokyo Metropolitan Geriatric Hospital.
Insights
Infective endocarditis (IE) and purulent pericarditis are serious cardiac infections. While IE demographics shift towards older patients with prosthetic valves, both conditions carry significant mortality risks requiring prompt diagnosis and treatment.
Area of Science:
- Cardiology
- Infectious Diseases
Background:
- Cardiac infections, primarily infective endocarditis (IE) and purulent pericarditis, pose significant health risks.
- Historically associated with rheumatic or congenital heart disease, IE now predominantly affects older individuals with prosthetic or degenerative heart conditions.
- Purulent pericarditis often presents as a complication of other severe illnesses, frequently lacking specific diagnostic signs.
Purpose of the Study:
- To summarize the current understanding of cardiac infections, including infective endocarditis and purulent pericarditis.
- To highlight diagnostic advancements and treatment strategies for these conditions.
- To underscore the associated mortality rates and risk factors.
Main Methods:
- Review of existing literature on infective endocarditis and purulent pericarditis.
- Analysis of diagnostic modalities, particularly echocardiography.
- Discussion of treatment principles focusing on antimicrobial therapy and surgical intervention.
Main Results:
- Infective endocarditis cases are increasingly observed in elderly patients with prosthetic cardiac valves and degenerative heart disease.
- Transesophageal echocardiography is a key diagnostic tool for IE.
- Complete organism eradication necessitates prolonged use of bactericidal agents to sterilize vegetations.
- Mortality for IE is reported at 10%, while purulent pericarditis carries a high mortality due to its frequent association with other critical diseases and often subtle presentation.
Conclusions:
- Effective management of cardiac infections requires timely diagnosis and aggressive antimicrobial therapy.
- The changing epidemiology of IE necessitates tailored treatment approaches for older patients and those with cardiac devices.
- High mortality rates associated with both IE and purulent pericarditis emphasize the need for continued research and improved clinical strategies.
Abstract:
Cardiac infection usually refers to infective endocarditis (IE) and purulent pericarditis. Though, IE was initially observed in patients with congenital or rheumatic heart disease, currently, persons with prosthetic cardiac valves and with degenerative heart disease account for the majority of the cases and there has been a significant trend toward an increase in the age of patients. Echocardiography, especially, transesophageal echocardiography, has provided valuable information for diagnosis. Since cure requires eradication of all the organisms, bactericidal agents must be used sufficient period to sterilize the vegetation. Overall mortality from recent reports is 10%. Purulent pericarditis almost always occurs in the setting of other serious disease and it's specific signs are often absent, so the disease still carries a high mortality.
More Related Videos
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Introduction Cardiac Emergencies

